News

VIB researchers discover possible strategy against stroke
7 January 2016
Research led by prof. Peter Carmeliet and dr. Annelies Quaegebeur (VIB/KU Leuven) indicates that inhibition of PHD1 offers protection against stroke, via an unexpected mechanism, raising hope for future stroke treatment.
Tech Lane Ghent Science Park
6 January 2016
The growth of the Biotech cluster in Ghent means that the available space at Technologiepark in Zwijnaarde is fully occupied. A number of other stakeholders have joined forces to start developing a new zone to the east of the Technologiepark.
Leuven Mindgate: dynamic network focusing on health, technology and creativity
6 January 2016
Leuven Mindgate brings partners together across sectors, government authorities and knowledge centers with the dual aim of guaranteeing sustainable development, innovation and prosperity in the Leuven region.
What a 'CERN' for agricultural science could look like
6 January 2016
Providing sufficient food to 9.2 billion people by 2050 in a changing climate will be a major challenge.
Hilde Windels (Biocartis) about the role of VIB in the Flemish biotech sector
5 January 2016
VIB wants to play a key role in the Flemish biotech sector. But how do others see us? We asked Hilde Windels, Biocartis’ Deputy CEO, who has been working in the Flemish biotech sector for almost 20 years.
VIB Discovery Sciences drives
4 January 2016
VIB’s mission is twofold: to conduct frontline research and to translate scientific breakthroughs into tangible benefits for society. VIB has endorsed the start of a strategic initiative called ‘VIB Discovery Sciences’.
First Closing of V-Bio Ventures
2 January 2016
V-Bio Ventures announced a first closing with capital commitments of € 63 million. We asked Christina Takke and Willem Broekaert, both Managing Partners and founders of V-Bio Ventures, to comment on what the next steps are.
Start me up! A closer look at new ventures based on breakthrough science
28 December 2015
VIB’s tech transfer system is a striking illustration of how ground-breaking science and impact on society go hand in hand. Our patents can lead to license agreements with existing companies, but also to brand-new ventures.
A novel mechanism that helps activated dendritic cells to initiate effective immunity
18 December 2015
Phagocytosis represents a critical innate barrier against infection and serves the clearance of extracellular microbes, infected and dying cells. The results are published in the December issue of the prestigious journal Immunity.
VIB Core Facilities: technology suites for better science
18 December 2015
In terms of new technologies VIB is experiencing more exciting times than ever. The same applies to VIB’s Core Facilities. As specialized units, they provide state-of-the-art equipment, expertise and experience.
Research reveals promising novel strategy to target cancer-causing protein
15 December 2015
A team of scientists, comprising researchers from IMCB, A*STAR, VIB/KU Leuven has revealed the mechanism by which tumor cells elevate levels of MDM4, a protein that is highly expressed in cancer cells but not in normal adult tissues.
One step closer towards to unravelling the origins of Alzheimer’s disease
15 December 2015
Which risk genes deserve a closer look in medical research on the origins of Alzheimer’s disease? In 2011, a genome-wide association study (GWAS) formulated an answer to this question.
A wake-up call for biomedical research on mouse models
15 December 2015
Tom Vanden Berghe and colleagues from the Peter Vandenabeele Lab (VIB/UGent) have demonstrated how the side effects of genetic modification of mice can complicate the interpretation of biomedical research.
Quickscan
15 December 2015
Several publications from VIB researchers
Tech Watch for adoption and development of novel technologies at VIB
15 December 2015
VIB’s Tech Watch program has helped establish many VIB projects with emerging companies in fields such as Microscopy, Genome Engineering, DNA synthesis, Sequencing, Protein Affinity Reagents, Protein Analysis and many more.

«Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS